Clinical Trials on Glabellar Crease
Total 10000 results
-
AstraZenecaCompleted
-
Novartis PharmaceuticalsRoche - Prof. Dr. Jens Huober et al.TerminatedMetastatic Breast CancerGermany
-
Eli Lilly and CompanyCompletedMetastatic Breast CancerJapan
-
Shanghai Henlius BiotechNot yet recruiting
-
Hebei Medical University Fourth HospitalNot yet recruiting
-
Halda Therapeutics OpCo, Inc.RecruitingMetastatic Breast CancerUnited States
-
Dana-Farber Cancer InstituteNot yet recruitingMetastatic Breast CancerUnited States
-
Samsung Medical CenterNovartisNot yet recruiting
-
University of UtahRecruitingMetastatic Breast CancerUnited States
-
UNICANCERRecruitingUnilateral Breast NeoplasmsFrance, Netherlands
-
Institut de Cancérologie de LorraineRecruiting
-
Hellenic Cooperative Oncology GroupCompletedEarly Breast CancerGreece
-
Tomsk National Research Medical Center of the Russian...Uppsala UniversityEnrolling by invitationPrimary Breast CancerRussia
-
Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical...Enrolling by invitationBreast Cancer FemalesTaiwan
-
Region Örebro CountyHelsinki University Central Hospital; Hospital Clinic of Barcelona; University... and other collaboratorsRecruitingQuality of Life | Advanced Breast Cancer | Metastatic Breast Cancer | Toxicity | Older PatientsSweden, Finland, Greece, Italy, Norway, Spain
-
Washington University School of MedicineGenomic Health®, Inc.RecruitingBreast Cancer | Breast Neoplasms | Cancer of Breast | Cancer of the BreastUnited States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedHER2/Neu Negative | Estrogen Receptor-positive Breast Cancer | Stage IV Breast Cancer AJCC v6 and v7United States
-
M.D. Anderson Cancer CenterCompletedInvasive Breast Carcinoma | Triple-Negative Breast CarcinomaUnited States
-
Ontario Clinical Oncology Group (OCOG)Cancer Care OntarioCompletedStage III Breast Cancer (T0N2, T1N2, T2N2, T3N1, 2 or T4) | Stage IIb Breast Cancer (T3N0)Canada
-
MedSIRPfizerCompletedBreast Cancer | Advanced Breast Cancer | Hormone Receptor Positive Tumor | Human Epidermal Growth Factor 2 Negative Carcinoma of BreastSpain, Germany, France, United Kingdom, Italy, Slovenia
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedInvasive Breast Carcinoma | HER2/Neu Negative | Breast Adenocarcinoma | Deleterious BRCA1 Gene Mutation | Deleterious BRCA2 Gene MutationUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)Active, not recruitingBone Metastases | Lung Metastases | HER2-positive Breast Cancer | Liver Metastases | Stage IV Breast Cancer | Recurrent Breast Cancer | Soft Tissue MetastasesUnited States
-
Gizem Cansiz UcarHacettepe University HospitalCompleted
-
Norfolk and Norwich University Hospitals NHS Foundation...CompletedBreast Cancer Related LymphoedemaUnited Kingdom
-
Instituto Nacional de Ciencias Medicas y Nutricion...UnknownTriple-Negative Invasive Breast Carcinoma | Residual TumorMexico
-
European Institute of OncologyRecruitingBreast Surgery | Breast Cancer | Endoscopic Video-assisted Nipple-sparing MastectomyItaly
-
Hao XuNot yet recruitingBreast Cancer | Breast Cancer With Low to Intermediate HER2 Expression
-
Kafkas UniversityNot yet recruitingBreast Cancer | Breast Self-ExaminationTurkey (Türkiye)
-
Cancer Institute and Hospital, Chinese Academy...Yunnan Cancer HospitalNot yet recruitingMetastatic Breast Cancer With HER2 Positive
-
Austrian Breast & Colorectal Cancer Study GroupNatera, Inc.RecruitingEarly and Locally Advanced Breast CancerAustria
-
Jonsson Comprehensive Cancer CenterPatient-Centered Outcomes Research Institute; University of California, San... and other collaboratorsRecruitingBreast Cancer Screening | Artificial Intelligence (AI)United States
-
Centre Leon BerardRecruitingPreoperative Magnetic Tracking in Breast Surgery in France: French Medical-economic Study. (MAGNETO)Breast Cancer | Breast Cancer Surgery | Medico-economic ImpactFrance
-
Henan Cancer HospitalNot yet recruitingBreast Cancer | Locally Advanced or Metastatic Breast Cancer
-
First Affiliated Hospital of Zhejiang UniversityRecruitingHR-positive,HER2-negative Breast CancerChina
-
Peking University People's HospitalRecruitingTriple Negative Breast CancerChina
-
Jiangsu Simcere Pharmaceutical Co., Ltd.Nanjing Zaiming Pharmaceutical Co., Ltd.RecruitingLocally Advanced or Metastatic Breast CancerChina
-
Shandong Suncadia Medicine Co., Ltd.RecruitingAdvanced Unresectable or Metastatic Breast CancerChina
-
Tianjin Medical University Cancer Institute and...Shenzhen New Industries Biomedical Engineering Co., Ltd.Not yet recruitingHER 2 Low-expressing Breast Cancer
-
University Hospital, GrenobleRecruitingBreast Cancer Female | Return to WorkFrance
-
German Cancer Research CenterGerman Federal Ministry of Education and Research; University Hospital HeidelbergRecruitingNeoadjuvant Therapy | Early-Stage Breast CancerGermany
-
The First Affiliated Hospital with Nanjing Medical...Not yet recruitingHormone Receptor-positive Advanced Breast Cancer
-
Fudan UniversityNot yet recruitingHormone Receptor-positive Advanced Breast Cancer
-
Cancer Institute and Hospital, Chinese Academy...RecruitingChemotherapy Effect | Locally Advanced Breast CancerChina
-
Second Affiliated Hospital, School of Medicine,...GeneCast Biotechnology Co., Ltd.RecruitingLuminal B/HER2-negative Breast CancerChina
-
Sun Yat-sen UniversityHunan Cancer Hospital; Beijing Biostar Pharmaceuticals Co., Ltd.RecruitingBreast Neoplasms | Locally Advanced or Metastatic Breast CancerChina
-
Vastra Gotaland RegionKarolinska University Hospital; Oslo University Hospital; University Hospital... and other collaboratorsRecruitingBreast Cancer Stage IV | Oligometastatic DiseaseSweden
-
Namida LabRecruitingBreast Cancer ScreeningUnited States
-
Second Affiliated Hospital, School of Medicine,...RecruitingHER2-positive Breast Cancer | Adjuvant TherapyChina
-
Assiut UniversityNot yet recruiting